chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: M
Vaccine: DTAP, HIBV, MMR, MMR, DTAP, HEP, HIBV, IPV, MMR
Symptoms: Abnormal behaviour, Acarodermatitis, Aggression, Autism, Autism spectrum disorder
Clinical narrative: This case was considered medically important. Additional information has been received pertaining to the reported product, patient demographics, medical history, additional adverse events, laboratory tests, immunizations and dates of administration. Information regarding Hib-Titer Vaccine was received from an attorney regarding an 18-month-old male patient who experienced bruxism, pica, PDD, autism, neurodevelopmental disorder, developmental incapacity, mental  and intellectual incapacity, permanent neurological damage, mercury poisoning and learning disabilities. The patient also received the fourth of DTaP on 29-Mar-1996. On 06-Nov-1997 the patient developed PDD, bruxism and pica. On unknown dates the patient also experienced neurodevelopmental disorder, developmental incapacity, autism, mental and intellectual incapacity, permanent neurological damage, mercury poisoning and learning disabilities. The outcome is unknown. DNA test for fragile X (results: negative) was done on 07-Jul-1997. No additional information was available at the time of this report.
Sex: M
Vaccine: DTAP, HIBV, MMR, MMR, DTAP, HEP, HIBV, IPV, MMR
Symptoms: Bruxism, Childhood disintegrative disorder, Cognitive disorder, Communication disorder, Condition aggravated
Clinical narrative: This case was considered medically important. Additional information has been received pertaining to the reported product, patient demographics, medical history, additional adverse events, laboratory tests, immunizations and dates of administration. Information regarding Hib-Titer Vaccine was received from an attorney regarding an 18-month-old male patient who experienced bruxism, pica, PDD, autism, neurodevelopmental disorder, developmental incapacity, mental  and intellectual incapacity, permanent neurological damage, mercury poisoning and learning disabilities. The patient also received the fourth of DTaP on 29-Mar-1996. On 06-Nov-1997 the patient developed PDD, bruxism and pica. On unknown dates the patient also experienced neurodevelopmental disorder, developmental incapacity, autism, mental and intellectual incapacity, permanent neurological damage, mercury poisoning and learning disabilities. The outcome is unknown. DNA test for fragile X (results: negative) was done on 07-Jul-1997. No additional information was available at the time of this report.
Sex: M
Vaccine: DTAP, HIBV, MMR, MMR, DTAP, HEP, HIBV, IPV, MMR
Symptoms: Conjunctivitis viral, Developmental delay, Ear pain, Eczema, Encopresis
Clinical narrative: This case was considered medically important. Additional information has been received pertaining to the reported product, patient demographics, medical history, additional adverse events, laboratory tests, immunizations and dates of administration. Information regarding Hib-Titer Vaccine was received from an attorney regarding an 18-month-old male patient who experienced bruxism, pica, PDD, autism, neurodevelopmental disorder, developmental incapacity, mental  and intellectual incapacity, permanent neurological damage, mercury poisoning and learning disabilities. The patient also received the fourth of DTaP on 29-Mar-1996. On 06-Nov-1997 the patient developed PDD, bruxism and pica. On unknown dates the patient also experienced neurodevelopmental disorder, developmental incapacity, autism, mental and intellectual incapacity, permanent neurological damage, mercury poisoning and learning disabilities. The outcome is unknown. DNA test for fragile X (results: negative) was done on 07-Jul-1997. No additional information was available at the time of this report.
Sex: M
Vaccine: DTAP, HIBV, MMR, MMR, DTAP, HEP, HIBV, IPV, MMR
Symptoms: Enuresis, Gastroenteritis viral, Learning disability, Learning disorder, Mental impairment
Clinical narrative: This case was considered medically important. Additional information has been received pertaining to the reported product, patient demographics, medical history, additional adverse events, laboratory tests, immunizations and dates of administration. Information regarding Hib-Titer Vaccine was received from an attorney regarding an 18-month-old male patient who experienced bruxism, pica, PDD, autism, neurodevelopmental disorder, developmental incapacity, mental  and intellectual incapacity, permanent neurological damage, mercury poisoning and learning disabilities. The patient also received the fourth of DTaP on 29-Mar-1996. On 06-Nov-1997 the patient developed PDD, bruxism and pica. On unknown dates the patient also experienced neurodevelopmental disorder, developmental incapacity, autism, mental and intellectual incapacity, permanent neurological damage, mercury poisoning and learning disabilities. The outcome is unknown. DNA test for fragile X (results: negative) was done on 07-Jul-1997. No additional information was available at the time of this report.
Sex: M
Vaccine: DTAP, HIBV, MMR, MMR, DTAP, HEP, HIBV, IPV, MMR
Symptoms: Mental retardation severity unspecified, Metal poisoning, Nerve injury, Neurodevelopmental disorder, Otitis media
Clinical narrative: This case was considered medically important. Additional information has been received pertaining to the reported product, patient demographics, medical history, additional adverse events, laboratory tests, immunizations and dates of administration. Information regarding Hib-Titer Vaccine was received from an attorney regarding an 18-month-old male patient who experienced bruxism, pica, PDD, autism, neurodevelopmental disorder, developmental incapacity, mental  and intellectual incapacity, permanent neurological damage, mercury poisoning and learning disabilities. The patient also received the fourth of DTaP on 29-Mar-1996. On 06-Nov-1997 the patient developed PDD, bruxism and pica. On unknown dates the patient also experienced neurodevelopmental disorder, developmental incapacity, autism, mental and intellectual incapacity, permanent neurological damage, mercury poisoning and learning disabilities. The outcome is unknown. DNA test for fragile X (results: negative) was done on 07-Jul-1997. No additional information was available at the time of this report.
Sex: M
Vaccine: DTAP, HIBV, MMR, MMR, DTAP, HEP, HIBV, IPV, MMR
Symptoms: Otitis media acute, Pharyngitis, Pharyngotonsillitis, Pityriasis rosea, Pneumonia
Clinical narrative: This case was considered medically important. Additional information has been received pertaining to the reported product, patient demographics, medical history, additional adverse events, laboratory tests, immunizations and dates of administration. Information regarding Hib-Titer Vaccine was received from an attorney regarding an 18-month-old male patient who experienced bruxism, pica, PDD, autism, neurodevelopmental disorder, developmental incapacity, mental  and intellectual incapacity, permanent neurological damage, mercury poisoning and learning disabilities. The patient also received the fourth of DTaP on 29-Mar-1996. On 06-Nov-1997 the patient developed PDD, bruxism and pica. On unknown dates the patient also experienced neurodevelopmental disorder, developmental incapacity, autism, mental and intellectual incapacity, permanent neurological damage, mercury poisoning and learning disabilities. The outcome is unknown. DNA test for fragile X (results: negative) was done on 07-Jul-1997. No additional information was available at the time of this report.
Sex: M
Vaccine: DTAP, HIBV, MMR, MMR, DTAP, HEP, HIBV, IPV, MMR
Symptoms: Rhinitis, Sinusitis, Social avoidant behaviour, Speech disorder, Speech disorder developmental
Clinical narrative: This case was considered medically important. Additional information has been received pertaining to the reported product, patient demographics, medical history, additional adverse events, laboratory tests, immunizations and dates of administration. Information regarding Hib-Titer Vaccine was received from an attorney regarding an 18-month-old male patient who experienced bruxism, pica, PDD, autism, neurodevelopmental disorder, developmental incapacity, mental  and intellectual incapacity, permanent neurological damage, mercury poisoning and learning disabilities. The patient also received the fourth of DTaP on 29-Mar-1996. On 06-Nov-1997 the patient developed PDD, bruxism and pica. On unknown dates the patient also experienced neurodevelopmental disorder, developmental incapacity, autism, mental and intellectual incapacity, permanent neurological damage, mercury poisoning and learning disabilities. The outcome is unknown. DNA test for fragile X (results: negative) was done on 07-Jul-1997. No additional information was available at the time of this report.
Sex: M
Vaccine: DTAP, HIBV, MMR, MMR, DTAP, HEP, HIBV, IPV, MMR
Symptoms: Teething, Temporomandibular joint syndrome, Tonsillitis, Unresponsive to stimuli, Upper respiratory tract infection
Clinical narrative: This case was considered medically important. Additional information has been received pertaining to the reported product, patient demographics, medical history, additional adverse events, laboratory tests, immunizations and dates of administration. Information regarding Hib-Titer Vaccine was received from an attorney regarding an 18-month-old male patient who experienced bruxism, pica, PDD, autism, neurodevelopmental disorder, developmental incapacity, mental  and intellectual incapacity, permanent neurological damage, mercury poisoning and learning disabilities. The patient also received the fourth of DTaP on 29-Mar-1996. On 06-Nov-1997 the patient developed PDD, bruxism and pica. On unknown dates the patient also experienced neurodevelopmental disorder, developmental incapacity, autism, mental and intellectual incapacity, permanent neurological damage, mercury poisoning and learning disabilities. The outcome is unknown. DNA test for fragile X (results: negative) was done on 07-Jul-1997. No additional information was available at the time of this report.
Sex: M
Vaccine: DTAP, HIBV, MMR, MMR, DTAP, HEP, HIBV, IPV, MMR
Symptoms: Viral infection
Clinical narrative: This case was considered medically important. Additional information has been received pertaining to the reported product, patient demographics, medical history, additional adverse events, laboratory tests, immunizations and dates of administration. Information regarding Hib-Titer Vaccine was received from an attorney regarding an 18-month-old male patient who experienced bruxism, pica, PDD, autism, neurodevelopmental disorder, developmental incapacity, mental  and intellectual incapacity, permanent neurological damage, mercury poisoning and learning disabilities. The patient also received the fourth of DTaP on 29-Mar-1996. On 06-Nov-1997 the patient developed PDD, bruxism and pica. On unknown dates the patient also experienced neurodevelopmental disorder, developmental incapacity, autism, mental and intellectual incapacity, permanent neurological damage, mercury poisoning and learning disabilities. The outcome is unknown. DNA test for fragile X (results: negative) was done on 07-Jul-1997. No additional information was available at the time of this report.
Sex: M
Vaccine: DTAP, HIBV, MMR, MMR, DTAP, HEP, HIBV, IPV, MMR
Symptoms: Abnormal behaviour, Acarodermatitis, Aggression, Antisocial behaviour, Aphasia
Clinical narrative: This case was considered medically important. Additional information has been received pertaining to the reported product, patient demographics, medical history, additional adverse events, laboratory tests, immunizations and dates of administration. Information regarding Hib-Titer Vaccine was received from an attorney regarding an 18-month-old male patient who experienced bruxism, pica, PDD, autism, neurodevelopmental disorder, developmental incapacity, mental  and intellectual incapacity, permanent neurological damage, mercury poisoning and learning disabilities. The patient also received the fourth of DTaP on 29-Mar-1996. On 06-Nov-1997 the patient developed PDD, bruxism and pica. On unknown dates the patient also experienced neurodevelopmental disorder, developmental incapacity, autism, mental and intellectual incapacity, permanent neurological damage, mercury poisoning and learning disabilities. The outcome is unknown. DNA test for fragile X (results: negative) was done on 07-Jul-1997. No additional information was available at the time of this report.
Sex: M
Vaccine: DTAP, HIBV, MMR, MMR, DTAP, HEP, HIBV, IPV, MMR
Symptoms: Autism, Autism spectrum disorder, Bruxism, Cognitive disorder, Communication disorder
Clinical narrative: This case was considered medically important. Additional information has been received pertaining to the reported product, patient demographics, medical history, additional adverse events, laboratory tests, immunizations and dates of administration. Information regarding Hib-Titer Vaccine was received from an attorney regarding an 18-month-old male patient who experienced bruxism, pica, PDD, autism, neurodevelopmental disorder, developmental incapacity, mental  and intellectual incapacity, permanent neurological damage, mercury poisoning and learning disabilities. The patient also received the fourth of DTaP on 29-Mar-1996. On 06-Nov-1997 the patient developed PDD, bruxism and pica. On unknown dates the patient also experienced neurodevelopmental disorder, developmental incapacity, autism, mental and intellectual incapacity, permanent neurological damage, mercury poisoning and learning disabilities. The outcome is unknown. DNA test for fragile X (results: negative) was done on 07-Jul-1997. No additional information was available at the time of this report.
Sex: M
Vaccine: DTAP, HIBV, MMR, MMR, DTAP, HEP, HIBV, IPV, MMR
Symptoms: Enuresis, Hypokinesia, Learning disability, Mental retardation severity unspecified, Metal poisoning
Clinical narrative: This case was considered medically important. Additional information has been received pertaining to the reported product, patient demographics, medical history, additional adverse events, laboratory tests, immunizations and dates of administration. Information regarding Hib-Titer Vaccine was received from an attorney regarding an 18-month-old male patient who experienced bruxism, pica, PDD, autism, neurodevelopmental disorder, developmental incapacity, mental  and intellectual incapacity, permanent neurological damage, mercury poisoning and learning disabilities. The patient also received the fourth of DTaP on 29-Mar-1996. On 06-Nov-1997 the patient developed PDD, bruxism and pica. On unknown dates the patient also experienced neurodevelopmental disorder, developmental incapacity, autism, mental and intellectual incapacity, permanent neurological damage, mercury poisoning and learning disabilities. The outcome is unknown. DNA test for fragile X (results: negative) was done on 07-Jul-1997. No additional information was available at the time of this report.
Sex: M
Vaccine: DTAP, HIBV, MMR, MMR, DTAP, HEP, HIBV, IPV, MMR
Symptoms: Nervous system disorder, Neurodevelopmental disorder, Otitis media, Pharyngitis, Pityriasis rosea
Clinical narrative: This case was considered medically important. Additional information has been received pertaining to the reported product, patient demographics, medical history, additional adverse events, laboratory tests, immunizations and dates of administration. Information regarding Hib-Titer Vaccine was received from an attorney regarding an 18-month-old male patient who experienced bruxism, pica, PDD, autism, neurodevelopmental disorder, developmental incapacity, mental  and intellectual incapacity, permanent neurological damage, mercury poisoning and learning disabilities. The patient also received the fourth of DTaP on 29-Mar-1996. On 06-Nov-1997 the patient developed PDD, bruxism and pica. On unknown dates the patient also experienced neurodevelopmental disorder, developmental incapacity, autism, mental and intellectual incapacity, permanent neurological damage, mercury poisoning and learning disabilities. The outcome is unknown. DNA test for fragile X (results: negative) was done on 07-Jul-1997. No additional information was available at the time of this report.
Sex: M
Vaccine: DTAP, HIBV, MMR, MMR, DTAP, HEP, HIBV, IPV, MMR
Symptoms: Pneumonia, Regressive behaviour, Rhinitis, Social avoidant behaviour, Speech disorder
Clinical narrative: This case was considered medically important. Additional information has been received pertaining to the reported product, patient demographics, medical history, additional adverse events, laboratory tests, immunizations and dates of administration. Information regarding Hib-Titer Vaccine was received from an attorney regarding an 18-month-old male patient who experienced bruxism, pica, PDD, autism, neurodevelopmental disorder, developmental incapacity, mental  and intellectual incapacity, permanent neurological damage, mercury poisoning and learning disabilities. The patient also received the fourth of DTaP on 29-Mar-1996. On 06-Nov-1997 the patient developed PDD, bruxism and pica. On unknown dates the patient also experienced neurodevelopmental disorder, developmental incapacity, autism, mental and intellectual incapacity, permanent neurological damage, mercury poisoning and learning disabilities. The outcome is unknown. DNA test for fragile X (results: negative) was done on 07-Jul-1997. No additional information was available at the time of this report.
Sex: M
Vaccine: DTAP, HIBV, MMR, MMR, DTAP, HEP, HIBV, IPV, MMR
Symptoms: Speech rehabilitation, Stereotypy, Teething, Temporomandibular joint syndrome, Tonsillar disorder
Clinical narrative: This case was considered medically important. Additional information has been received pertaining to the reported product, patient demographics, medical history, additional adverse events, laboratory tests, immunizations and dates of administration. Information regarding Hib-Titer Vaccine was received from an attorney regarding an 18-month-old male patient who experienced bruxism, pica, PDD, autism, neurodevelopmental disorder, developmental incapacity, mental  and intellectual incapacity, permanent neurological damage, mercury poisoning and learning disabilities. The patient also received the fourth of DTaP on 29-Mar-1996. On 06-Nov-1997 the patient developed PDD, bruxism and pica. On unknown dates the patient also experienced neurodevelopmental disorder, developmental incapacity, autism, mental and intellectual incapacity, permanent neurological damage, mercury poisoning and learning disabilities. The outcome is unknown. DNA test for fragile X (results: negative) was done on 07-Jul-1997. No additional information was available at the time of this report.
Sex: M
Vaccine: DTAP, HIBV, MMR, MMR, DTAP, HEP, HIBV, IPV, MMR
Symptoms: Unresponsive to stimuli, Upper respiratory tract infection, Viral infection
Clinical narrative: This case was considered medically important. Additional information has been received pertaining to the reported product, patient demographics, medical history, additional adverse events, laboratory tests, immunizations and dates of administration. Information regarding Hib-Titer Vaccine was received from an attorney regarding an 18-month-old male patient who experienced bruxism, pica, PDD, autism, neurodevelopmental disorder, developmental incapacity, mental  and intellectual incapacity, permanent neurological damage, mercury poisoning and learning disabilities. The patient also received the fourth of DTaP on 29-Mar-1996. On 06-Nov-1997 the patient developed PDD, bruxism and pica. On unknown dates the patient also experienced neurodevelopmental disorder, developmental incapacity, autism, mental and intellectual incapacity, permanent neurological damage, mercury poisoning and learning disabilities. The outcome is unknown. DNA test for fragile X (results: negative) was done on 07-Jul-1997. No additional information was available at the time of this report.
Age: 0.5
Sex: M
Vaccine: DTP, HEP, HIBV, OPV, HEP, DTAP, DTPHIB, HEP, HIBV, MMR, OPV
Symptoms: Autism, Autism spectrum disorder, Developmental delay, Learning disability, Mental impairment
Clinical narrative: Additional information was received via medical records, alleging the patient experienced the additional events of autism, neurodevelopmental disorder and pervasive developmental disorder and provided vaccines administered dates and lot numbers. This case was considered medically important. Information regarding Hib-Titer was received from an attorney regarding a male patient who received a third dose on 27-Dec-1996 along a third dose of DTP. The patient mercury poisoning and learning disability. A legal complaint was received from an attorney alleging that a male child received a dose of Hib-Titer along with other childhood vaccines. According to the legal complaint the child was "perfectly normal and healthy at birth, developed normally and demonstrated social, cognitive, behavioral and physical age-appropriate skills." According to the legal complaint the child was exposed to "cumulative toxic levels "was caused to suffer serious and permanent neurological damage...to include past and future mental, intellectual, developmental and neurological incapacity and associated learning disabilities, disorders and impairments". Additionally, it is alleged the child developed Autism and neurodevelopmental disorder. In Feb-2000, the patient was diagnosed with Pervasive developmental disorder. The patient's outcome is unknown. No additional information was available at the time of this report.
Age: 0.5
Sex: M
Vaccine: DTP, HEP, HIBV, OPV, HEP, DTAP, DTPHIB, HEP, HIBV, MMR, OPV
Symptoms: Metal poisoning, Nervous system disorder, Neurodevelopmental disorder
Clinical narrative: Additional information was received via medical records, alleging the patient experienced the additional events of autism, neurodevelopmental disorder and pervasive developmental disorder and provided vaccines administered dates and lot numbers. This case was considered medically important. Information regarding Hib-Titer was received from an attorney regarding a male patient who received a third dose on 27-Dec-1996 along a third dose of DTP. The patient mercury poisoning and learning disability. A legal complaint was received from an attorney alleging that a male child received a dose of Hib-Titer along with other childhood vaccines. According to the legal complaint the child was "perfectly normal and healthy at birth, developed normally and demonstrated social, cognitive, behavioral and physical age-appropriate skills." According to the legal complaint the child was exposed to "cumulative toxic levels "was caused to suffer serious and permanent neurological damage...to include past and future mental, intellectual, developmental and neurological incapacity and associated learning disabilities, disorders and impairments". Additionally, it is alleged the child developed Autism and neurodevelopmental disorder. In Feb-2000, the patient was diagnosed with Pervasive developmental disorder. The patient's outcome is unknown. No additional information was available at the time of this report.
Age: 0.5
Sex: M
Vaccine: DTP, HEP, HIBV, OPV, HEP, DTAP, DTPHIB, HEP, HIBV, MMR, OPV
Symptoms: Antisocial behaviour, Apgar score normal, Aphasia, Autism, Autism spectrum disorder
Clinical narrative: Additional information was received via medical records, alleging the patient experienced the additional events of autism, neurodevelopmental disorder and pervasive developmental disorder and provided vaccines administered dates and lot numbers. This case was considered medically important. Information regarding Hib-Titer was received from an attorney regarding a male patient who received a third dose on 27-Dec-1996 along a third dose of DTP. The patient mercury poisoning and learning disability. A legal complaint was received from an attorney alleging that a male child received a dose of Hib-Titer along with other childhood vaccines. According to the legal complaint the child was "perfectly normal and healthy at birth, developed normally and demonstrated social, cognitive, behavioral and physical age-appropriate skills." According to the legal complaint the child was exposed to "cumulative toxic levels "was caused to suffer serious and permanent neurological damage...to include past and future mental, intellectual, developmental and neurological incapacity and associated learning disabilities, disorders and impairments". Additionally, it is alleged the child developed Autism and neurodevelopmental disorder. In Feb-2000, the patient was diagnosed with Pervasive developmental disorder. The patient's outcome is unknown. No additional information was available at the time of this report.
Age: 0.5
Sex: M
Vaccine: DTP, HEP, HIBV, OPV, HEP, DTAP, DTPHIB, HEP, HIBV, MMR, OPV
Symptoms: Childhood disintegrative disorder, Cognitive disorder, Decreased appetite, Developmental delay, Diarrhoea
Clinical narrative: Additional information was received via medical records, alleging the patient experienced the additional events of autism, neurodevelopmental disorder and pervasive developmental disorder and provided vaccines administered dates and lot numbers. This case was considered medically important. Information regarding Hib-Titer was received from an attorney regarding a male patient who received a third dose on 27-Dec-1996 along a third dose of DTP. The patient mercury poisoning and learning disability. A legal complaint was received from an attorney alleging that a male child received a dose of Hib-Titer along with other childhood vaccines. According to the legal complaint the child was "perfectly normal and healthy at birth, developed normally and demonstrated social, cognitive, behavioral and physical age-appropriate skills." According to the legal complaint the child was exposed to "cumulative toxic levels "was caused to suffer serious and permanent neurological damage...to include past and future mental, intellectual, developmental and neurological incapacity and associated learning disabilities, disorders and impairments". Additionally, it is alleged the child developed Autism and neurodevelopmental disorder. In Feb-2000, the patient was diagnosed with Pervasive developmental disorder. The patient's outcome is unknown. No additional information was available at the time of this report.
Age: 0.5
Sex: M
Vaccine: DTP, HEP, HIBV, OPV, HEP, DTAP, DTPHIB, HEP, HIBV, MMR, OPV
Symptoms: Expressive language disorder, Hypokinesia, Irritability, Learning disability, Mental disorder
Clinical narrative: Additional information was received via medical records, alleging the patient experienced the additional events of autism, neurodevelopmental disorder and pervasive developmental disorder and provided vaccines administered dates and lot numbers. This case was considered medically important. Information regarding Hib-Titer was received from an attorney regarding a male patient who received a third dose on 27-Dec-1996 along a third dose of DTP. The patient mercury poisoning and learning disability. A legal complaint was received from an attorney alleging that a male child received a dose of Hib-Titer along with other childhood vaccines. According to the legal complaint the child was "perfectly normal and healthy at birth, developed normally and demonstrated social, cognitive, behavioral and physical age-appropriate skills." According to the legal complaint the child was exposed to "cumulative toxic levels "was caused to suffer serious and permanent neurological damage...to include past and future mental, intellectual, developmental and neurological incapacity and associated learning disabilities, disorders and impairments". Additionally, it is alleged the child developed Autism and neurodevelopmental disorder. In Feb-2000, the patient was diagnosed with Pervasive developmental disorder. The patient's outcome is unknown. No additional information was available at the time of this report.
Age: 0.5
Sex: M
Vaccine: DTP, HEP, HIBV, OPV, HEP, DTAP, DTPHIB, HEP, HIBV, MMR, OPV
Symptoms: Mental impairment, Metal poisoning, Nasal congestion, Nasopharyngitis, Nervous system disorder
Clinical narrative: Additional information was received via medical records, alleging the patient experienced the additional events of autism, neurodevelopmental disorder and pervasive developmental disorder and provided vaccines administered dates and lot numbers. This case was considered medically important. Information regarding Hib-Titer was received from an attorney regarding a male patient who received a third dose on 27-Dec-1996 along a third dose of DTP. The patient mercury poisoning and learning disability. A legal complaint was received from an attorney alleging that a male child received a dose of Hib-Titer along with other childhood vaccines. According to the legal complaint the child was "perfectly normal and healthy at birth, developed normally and demonstrated social, cognitive, behavioral and physical age-appropriate skills." According to the legal complaint the child was exposed to "cumulative toxic levels "was caused to suffer serious and permanent neurological damage...to include past and future mental, intellectual, developmental and neurological incapacity and associated learning disabilities, disorders and impairments". Additionally, it is alleged the child developed Autism and neurodevelopmental disorder. In Feb-2000, the patient was diagnosed with Pervasive developmental disorder. The patient's outcome is unknown. No additional information was available at the time of this report.
Age: 0.5
Sex: M
Vaccine: DTP, HEP, HIBV, OPV, HEP, DTAP, DTPHIB, HEP, HIBV, MMR, OPV
Symptoms: Neurological symptom, Ocular hyperaemia, Otitis media acute, Pharyngolaryngeal pain, Psychomotor skills impaired
Clinical narrative: Additional information was received via medical records, alleging the patient experienced the additional events of autism, neurodevelopmental disorder and pervasive developmental disorder and provided vaccines administered dates and lot numbers. This case was considered medically important. Information regarding Hib-Titer was received from an attorney regarding a male patient who received a third dose on 27-Dec-1996 along a third dose of DTP. The patient mercury poisoning and learning disability. A legal complaint was received from an attorney alleging that a male child received a dose of Hib-Titer along with other childhood vaccines. According to the legal complaint the child was "perfectly normal and healthy at birth, developed normally and demonstrated social, cognitive, behavioral and physical age-appropriate skills." According to the legal complaint the child was exposed to "cumulative toxic levels "was caused to suffer serious and permanent neurological damage...to include past and future mental, intellectual, developmental and neurological incapacity and associated learning disabilities, disorders and impairments". Additionally, it is alleged the child developed Autism and neurodevelopmental disorder. In Feb-2000, the patient was diagnosed with Pervasive developmental disorder. The patient's outcome is unknown. No additional information was available at the time of this report.
Age: 0.5
Sex: M
Vaccine: DTP, HEP, HIBV, OPV, HEP, DTAP, DTPHIB, HEP, HIBV, MMR, OPV
Symptoms: Pyrexia, Regressive behaviour, Respiratory tract congestion, Rhinitis, Rhinorrhoea
Clinical narrative: Additional information was received via medical records, alleging the patient experienced the additional events of autism, neurodevelopmental disorder and pervasive developmental disorder and provided vaccines administered dates and lot numbers. This case was considered medically important. Information regarding Hib-Titer was received from an attorney regarding a male patient who received a third dose on 27-Dec-1996 along a third dose of DTP. The patient mercury poisoning and learning disability. A legal complaint was received from an attorney alleging that a male child received a dose of Hib-Titer along with other childhood vaccines. According to the legal complaint the child was "perfectly normal and healthy at birth, developed normally and demonstrated social, cognitive, behavioral and physical age-appropriate skills." According to the legal complaint the child was exposed to "cumulative toxic levels "was caused to suffer serious and permanent neurological damage...to include past and future mental, intellectual, developmental and neurological incapacity and associated learning disabilities, disorders and impairments". Additionally, it is alleged the child developed Autism and neurodevelopmental disorder. In Feb-2000, the patient was diagnosed with Pervasive developmental disorder. The patient's outcome is unknown. No additional information was available at the time of this report.
Age: 0.5
Sex: M
Vaccine: DTP, HEP, HIBV, OPV, HEP, DTAP, DTPHIB, HEP, HIBV, MMR, OPV
Symptoms: Social avoidant behaviour, Speech disorder, Stereotypy, Unresponsive to stimuli, Vomiting
Clinical narrative: Additional information was received via medical records, alleging the patient experienced the additional events of autism, neurodevelopmental disorder and pervasive developmental disorder and provided vaccines administered dates and lot numbers. This case was considered medically important. Information regarding Hib-Titer was received from an attorney regarding a male patient who received a third dose on 27-Dec-1996 along a third dose of DTP. The patient mercury poisoning and learning disability. A legal complaint was received from an attorney alleging that a male child received a dose of Hib-Titer along with other childhood vaccines. According to the legal complaint the child was "perfectly normal and healthy at birth, developed normally and demonstrated social, cognitive, behavioral and physical age-appropriate skills." According to the legal complaint the child was exposed to "cumulative toxic levels "was caused to suffer serious and permanent neurological damage...to include past and future mental, intellectual, developmental and neurological incapacity and associated learning disabilities, disorders and impairments". Additionally, it is alleged the child developed Autism and neurodevelopmental disorder. In Feb-2000, the patient was diagnosed with Pervasive developmental disorder. The patient's outcome is unknown. No additional information was available at the time of this report.
Age: 0.5
Sex: M
Vaccine: DTP, HEP, HIBV, OPV, HEP, DTAP, DTPHIB, HEP, HIBV, MMR, OPV
Symptoms: Apgar score normal, Aphasia, Autism, Autism spectrum disorder, Childhood disintegrative disorder
Clinical narrative: Additional information was received via medical records, alleging the patient experienced the additional events of autism, neurodevelopmental disorder and pervasive developmental disorder and provided vaccines administered dates and lot numbers. This case was considered medically important. Information regarding Hib-Titer was received from an attorney regarding a male patient who received a third dose on 27-Dec-1996 along a third dose of DTP. The patient mercury poisoning and learning disability. A legal complaint was received from an attorney alleging that a male child received a dose of Hib-Titer along with other childhood vaccines. According to the legal complaint the child was "perfectly normal and healthy at birth, developed normally and demonstrated social, cognitive, behavioral and physical age-appropriate skills." According to the legal complaint the child was exposed to "cumulative toxic levels "was caused to suffer serious and permanent neurological damage...to include past and future mental, intellectual, developmental and neurological incapacity and associated learning disabilities, disorders and impairments". Additionally, it is alleged the child developed Autism and neurodevelopmental disorder. In Feb-2000, the patient was diagnosed with Pervasive developmental disorder. The patient's outcome is unknown. No additional information was available at the time of this report.
Age: 0.5
Sex: M
Vaccine: DTP, HEP, HIBV, OPV, HEP, DTAP, DTPHIB, HEP, HIBV, MMR, OPV
Symptoms: Cognitive disorder, Decreased appetite, Developmental delay, Diarrhoea, Hypokinesia
Clinical narrative: Additional information was received via medical records, alleging the patient experienced the additional events of autism, neurodevelopmental disorder and pervasive developmental disorder and provided vaccines administered dates and lot numbers. This case was considered medically important. Information regarding Hib-Titer was received from an attorney regarding a male patient who received a third dose on 27-Dec-1996 along a third dose of DTP. The patient mercury poisoning and learning disability. A legal complaint was received from an attorney alleging that a male child received a dose of Hib-Titer along with other childhood vaccines. According to the legal complaint the child was "perfectly normal and healthy at birth, developed normally and demonstrated social, cognitive, behavioral and physical age-appropriate skills." According to the legal complaint the child was exposed to "cumulative toxic levels "was caused to suffer serious and permanent neurological damage...to include past and future mental, intellectual, developmental and neurological incapacity and associated learning disabilities, disorders and impairments". Additionally, it is alleged the child developed Autism and neurodevelopmental disorder. In Feb-2000, the patient was diagnosed with Pervasive developmental disorder. The patient's outcome is unknown. No additional information was available at the time of this report.
Age: 0.5
Sex: M
Vaccine: DTP, HEP, HIBV, OPV, HEP, DTAP, DTPHIB, HEP, HIBV, MMR, OPV
Symptoms: Inappropriate schedule of drug administration, Irritability, Learning disability, Mental disorder, Mental impairment
Clinical narrative: Additional information was received via medical records, alleging the patient experienced the additional events of autism, neurodevelopmental disorder and pervasive developmental disorder and provided vaccines administered dates and lot numbers. This case was considered medically important. Information regarding Hib-Titer was received from an attorney regarding a male patient who received a third dose on 27-Dec-1996 along a third dose of DTP. The patient mercury poisoning and learning disability. A legal complaint was received from an attorney alleging that a male child received a dose of Hib-Titer along with other childhood vaccines. According to the legal complaint the child was "perfectly normal and healthy at birth, developed normally and demonstrated social, cognitive, behavioral and physical age-appropriate skills." According to the legal complaint the child was exposed to "cumulative toxic levels "was caused to suffer serious and permanent neurological damage...to include past and future mental, intellectual, developmental and neurological incapacity and associated learning disabilities, disorders and impairments". Additionally, it is alleged the child developed Autism and neurodevelopmental disorder. In Feb-2000, the patient was diagnosed with Pervasive developmental disorder. The patient's outcome is unknown. No additional information was available at the time of this report.
Age: 0.5
Sex: M
Vaccine: DTP, HEP, HIBV, OPV, HEP, DTAP, DTPHIB, HEP, HIBV, MMR, OPV
Symptoms: Metal poisoning, Motor dysfunction, Nasopharyngitis, Nervous system disorder, Neurological symptom
Clinical narrative: Additional information was received via medical records, alleging the patient experienced the additional events of autism, neurodevelopmental disorder and pervasive developmental disorder and provided vaccines administered dates and lot numbers. This case was considered medically important. Information regarding Hib-Titer was received from an attorney regarding a male patient who received a third dose on 27-Dec-1996 along a third dose of DTP. The patient mercury poisoning and learning disability. A legal complaint was received from an attorney alleging that a male child received a dose of Hib-Titer along with other childhood vaccines. According to the legal complaint the child was "perfectly normal and healthy at birth, developed normally and demonstrated social, cognitive, behavioral and physical age-appropriate skills." According to the legal complaint the child was exposed to "cumulative toxic levels "was caused to suffer serious and permanent neurological damage...to include past and future mental, intellectual, developmental and neurological incapacity and associated learning disabilities, disorders and impairments". Additionally, it is alleged the child developed Autism and neurodevelopmental disorder. In Feb-2000, the patient was diagnosed with Pervasive developmental disorder. The patient's outcome is unknown. No additional information was available at the time of this report.
Age: 0.5
Sex: M
Vaccine: DTP, HEP, HIBV, OPV, HEP, DTAP, DTPHIB, HEP, HIBV, MMR, OPV
Symptoms: Ocular hyperaemia, Otitis media acute, Pharyngolaryngeal pain, Pyrexia, Respiratory tract congestion
Clinical narrative: Additional information was received via medical records, alleging the patient experienced the additional events of autism, neurodevelopmental disorder and pervasive developmental disorder and provided vaccines administered dates and lot numbers. This case was considered medically important. Information regarding Hib-Titer was received from an attorney regarding a male patient who received a third dose on 27-Dec-1996 along a third dose of DTP. The patient mercury poisoning and learning disability. A legal complaint was received from an attorney alleging that a male child received a dose of Hib-Titer along with other childhood vaccines. According to the legal complaint the child was "perfectly normal and healthy at birth, developed normally and demonstrated social, cognitive, behavioral and physical age-appropriate skills." According to the legal complaint the child was exposed to "cumulative toxic levels "was caused to suffer serious and permanent neurological damage...to include past and future mental, intellectual, developmental and neurological incapacity and associated learning disabilities, disorders and impairments". Additionally, it is alleged the child developed Autism and neurodevelopmental disorder. In Feb-2000, the patient was diagnosed with Pervasive developmental disorder. The patient's outcome is unknown. No additional information was available at the time of this report.
Age: 0.5
Sex: M
Vaccine: DTP, HEP, HIBV, OPV, HEP, DTAP, DTPHIB, HEP, HIBV, MMR, OPV
Symptoms: Rhinitis, Rhinorrhoea, Social avoidant behaviour, Speech disorder developmental, Stereotypy
Clinical narrative: Additional information was received via medical records, alleging the patient experienced the additional events of autism, neurodevelopmental disorder and pervasive developmental disorder and provided vaccines administered dates and lot numbers. This case was considered medically important. Information regarding Hib-Titer was received from an attorney regarding a male patient who received a third dose on 27-Dec-1996 along a third dose of DTP. The patient mercury poisoning and learning disability. A legal complaint was received from an attorney alleging that a male child received a dose of Hib-Titer along with other childhood vaccines. According to the legal complaint the child was "perfectly normal and healthy at birth, developed normally and demonstrated social, cognitive, behavioral and physical age-appropriate skills." According to the legal complaint the child was exposed to "cumulative toxic levels "was caused to suffer serious and permanent neurological damage...to include past and future mental, intellectual, developmental and neurological incapacity and associated learning disabilities, disorders and impairments". Additionally, it is alleged the child developed Autism and neurodevelopmental disorder. In Feb-2000, the patient was diagnosed with Pervasive developmental disorder. The patient's outcome is unknown. No additional information was available at the time of this report.
Age: 0.5
Sex: M
Vaccine: DTP, HEP, HIBV, OPV, HEP, DTAP, DTPHIB, HEP, HIBV, MMR, OPV
Symptoms: Unresponsive to stimuli, Vomiting
Clinical narrative: Additional information was received via medical records, alleging the patient experienced the additional events of autism, neurodevelopmental disorder and pervasive developmental disorder and provided vaccines administered dates and lot numbers. This case was considered medically important. Information regarding Hib-Titer was received from an attorney regarding a male patient who received a third dose on 27-Dec-1996 along a third dose of DTP. The patient mercury poisoning and learning disability. A legal complaint was received from an attorney alleging that a male child received a dose of Hib-Titer along with other childhood vaccines. According to the legal complaint the child was "perfectly normal and healthy at birth, developed normally and demonstrated social, cognitive, behavioral and physical age-appropriate skills." According to the legal complaint the child was exposed to "cumulative toxic levels "was caused to suffer serious and permanent neurological damage...to include past and future mental, intellectual, developmental and neurological incapacity and associated learning disabilities, disorders and impairments". Additionally, it is alleged the child developed Autism and neurodevelopmental disorder. In Feb-2000, the patient was diagnosed with Pervasive developmental disorder. The patient's outcome is unknown. No additional information was available at the time of this report.
Age: 1.4
Sex: M
Vaccine: DTAP, HEP, HIBV, IPV, HEP
Symptoms: Autism, Autism spectrum disorder, Blood lead normal, DNA test for fragile X, Encephalopathy
Clinical narrative: Follow-up information was received that provided patient gender, suspect vaccines, additional events and laboratory test results. This case was considered medically important. Medical records regarding Hib were received from an attorney regarding a male patient received the fourth dose on 25-Oct-2000 along with the third dose of IPOL (manufacturer unknown) and the fourth dose of DTaP (manufacturer unknown) at the age of 17 months and experienced encephalopathy, pervasive developmental disorder NOS, autism, neurodevelopmental disorder, pica, delayed language and mercury poisoning. On 25-Oct-2000, the patient received the fourth dose of Hib along with other childhood vaccines. The child received vaccines from birth up to 18 months of age, age allegedly  experienced mercury poisoning as a  result of the cumulative exposure to mercury in the vaccines. On an unspecified date, the patient experienced autism, neurodevelopmental disorder, pica, and delayed language. In Nov-2001, the child was diagnosed with encephalopathy. In Jan-2002, the patient was diagnosed with pervasive developmental disorder NOS. It was unknown if the patient recovered from the events. DNA test fragile X (results: negative) was done on 06-Feb-2002. Blood lead (results: 5 ug/dL) was done in 24-Feb-2003. No additional information was available at the time of this report.
Age: 1.4
Sex: M
Vaccine: DTAP, HEP, HIBV, IPV, HEP
Symptoms: Metal poisoning, Neurodevelopmental disorder, Pica, Speech disorder developmental
Clinical narrative: Follow-up information was received that provided patient gender, suspect vaccines, additional events and laboratory test results. This case was considered medically important. Medical records regarding Hib were received from an attorney regarding a male patient received the fourth dose on 25-Oct-2000 along with the third dose of IPOL (manufacturer unknown) and the fourth dose of DTaP (manufacturer unknown) at the age of 17 months and experienced encephalopathy, pervasive developmental disorder NOS, autism, neurodevelopmental disorder, pica, delayed language and mercury poisoning. On 25-Oct-2000, the patient received the fourth dose of Hib along with other childhood vaccines. The child received vaccines from birth up to 18 months of age, age allegedly  experienced mercury poisoning as a  result of the cumulative exposure to mercury in the vaccines. On an unspecified date, the patient experienced autism, neurodevelopmental disorder, pica, and delayed language. In Nov-2001, the child was diagnosed with encephalopathy. In Jan-2002, the patient was diagnosed with pervasive developmental disorder NOS. It was unknown if the patient recovered from the events. DNA test fragile X (results: negative) was done on 06-Feb-2002. Blood lead (results: 5 ug/dL) was done in 24-Feb-2003. No additional information was available at the time of this report.